中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2014年
3期
195-197
,共3页
刘颖%薄晓霞%郭子臣%谢美云%金兰花
劉穎%薄曉霞%郭子臣%謝美雲%金蘭花
류영%박효하%곽자신%사미운%금란화
慢性阻塞性肺疾病%无创正压通气%呼吸衰竭
慢性阻塞性肺疾病%無創正壓通氣%呼吸衰竭
만성조새성폐질병%무창정압통기%호흡쇠갈
Chronic obstructive pulmonary disease%Noninvasive positive pressure ventilation%Acute exacerbation
目的:评价无创正压通气治疗慢性阻塞性肺疾病急性加重期合并呼吸衰竭的临床疗效。方法将2012年10月~2013年8月收治的40例慢性阻塞性肺疾病急性加重期患者按随机数表分为对照组(n=20)和NIPPV组(n=20),两组均给予常规治疗,NIPPV组在常规治疗基础上加用无创正压通气治疗。治疗1周后比较两组患者心率、呼吸频率、血气指标的变化及疗效。结果 NIPPV组的呼吸频率、心率、血气指标的改善水平均显著优于对照组,两组比较差异有统计学意义(P<0.05);NIPPV组的治疗效果显著优于对照组,两组比较差异有统计学意义(P<0.05)。结论无创正压通气结合常规疗法能有效提高慢性阻塞性肺疾病急性加重期的疗效。
目的:評價無創正壓通氣治療慢性阻塞性肺疾病急性加重期閤併呼吸衰竭的臨床療效。方法將2012年10月~2013年8月收治的40例慢性阻塞性肺疾病急性加重期患者按隨機數錶分為對照組(n=20)和NIPPV組(n=20),兩組均給予常規治療,NIPPV組在常規治療基礎上加用無創正壓通氣治療。治療1週後比較兩組患者心率、呼吸頻率、血氣指標的變化及療效。結果 NIPPV組的呼吸頻率、心率、血氣指標的改善水平均顯著優于對照組,兩組比較差異有統計學意義(P<0.05);NIPPV組的治療效果顯著優于對照組,兩組比較差異有統計學意義(P<0.05)。結論無創正壓通氣結閤常規療法能有效提高慢性阻塞性肺疾病急性加重期的療效。
목적:평개무창정압통기치료만성조새성폐질병급성가중기합병호흡쇠갈적림상료효。방법장2012년10월~2013년8월수치적40례만성조새성폐질병급성가중기환자안수궤수표분위대조조(n=20)화NIPPV조(n=20),량조균급여상규치료,NIPPV조재상규치료기출상가용무창정압통기치료。치료1주후비교량조환자심솔、호흡빈솔、혈기지표적변화급료효。결과 NIPPV조적호흡빈솔、심솔、혈기지표적개선수평균현저우우대조조,량조비교차이유통계학의의(P<0.05);NIPPV조적치료효과현저우우대조조,량조비교차이유통계학의의(P<0.05)。결론무창정압통기결합상규요법능유효제고만성조새성폐질병급성가중기적료효。
Objective To evaluate the clinical efficacy of noninvasive positive pressure ventilation (NIPPV) for patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods Forty AECOPD patients from 2012 Ocotober to 2013 August were recruited and assigned to standard treatment group(n=20) and NIPPV treatment group(n=15).NIPPV group was received standard treatment plus NIPPV treatment. The heart rate, respiratory rate and arterial blood gas of two groups were compared. Results The changes of heart rate, respiratory rate and arterial blood gas of NIPPV group were better than standard group.There was a significant difference between the two groups (P < 0.05).The clinical efficacy of NIPPV group was better than standard group. There was a significant difference between the two groups (P < 0.05). Conclusion NIPPV combined standard treatment can improve the clinical efficacy of patients with acute exacerbation of chronic obstructive pulmonary disease.